Document Detail


Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
MedLine Citation:
PMID:  20516248     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
Authors:
Antonio Gutierrez; Sunil V Rao
Related Documents :
18403088 - Emergent diagnosis of acute coronary syndromes: today's challenges and tomorrow's possi...
20609798 - Off-pump coronary artery bypass grafting in a patient with bernard-soulier syndrome.
7492168 - Management of infantile polyposis syndrome.
5774318 - Severe self-poisoning in sunderland.
19987248 - Edward selleck hare (1812-1838) and the syndrome of paralysis of the cervical sympathetic.
10854818 - Thrombotic microangiopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  77     ISSN:  1939-2869     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-02     Completed Date:  2010-09-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  369-79     Citation Subset:  IM    
Affiliation:
Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. antonio.gutierrez@duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / complications*,  drug therapy*
Fibrinolytic Agents / adverse effects*,  therapeutic use
Hemorrhage / chemically induced*,  etiology*
Humans
Incidence
Platelet Aggregation Inhibitors / adverse effects*,  therapeutic use
Prognosis
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recurrent spontaneous pneumothorax.
Next Document:  Left ventricular hypertrophy: An overlooked cardiovascular risk factor.